Jose Quesada
Internal Medicine · Vero Beach, FLNPI 1740749712
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 74.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $2,226 and has fallen 93.6% since, to $142 in 2025.
Across 43 payments — averaging $85.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Coloplast$762
- AbbVie$109
- Edwards Lifesciences$69
What the payments were for
- Travel & lodging$1,78649%
- Food & beverage$1,79949%
- Education$912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 31 | $2,735 |
| Coloplast | 10 | $762 |
| AbbVie | 1 | $109 |
| Edwards Lifesciences | 1 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700 CXR RTE KIT$987
- TITAN$356
- GENERAL ERECTILE DYSFUNCTION$305
- GENERAL VASCULAR ACCESS$250
- Spectra$147
- Rinvoq$109
How this compares
$3,676 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $17,084 |
| Pantoprazole Sodium | 39 | $462 |
| Rosuvastatin Calcium | 37 | $454 |
| Metoprolol Succinate | 38 | $375 |
| Cefdinir | 34 | $293 |
| Atorvastatin Calcium | 27 | $250 |
| Doxycycline Hyclate | 28 | $215 |
| Amlodipine Besylate | 39 | $208 |
| ClopidogrelClopidogrel Bisulfate | 20 | $180 |
| Levothyroxine Sodium | 14 | $171 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $140 |
| Mirtazapine | 11 | $128 |
| Gabapentin | 15 | $109 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $100 |
| Furosemide | 37 | $98 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Vero Beach
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.